BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2674499)

  • 1. Postoperative changes in hemostasis analyzed by the serial determination of fibrinopeptides and D-dimer.
    Kang J; Kambayashi J; Sakon M; Tsujinaka T; Mori T
    Jpn J Surg; 1989 May; 19(3):262-8. PubMed ID: 2674499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of coagulation and fibrinolysis during surgery, analyzed by molecular markers.
    Kambayashi J; Sakon M; Yokota M; Shiba E; Kawasaki T; Mori T
    Thromb Res; 1990 Oct; 60(2):157-67. PubMed ID: 2149215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Coagulation and fibrinolysis in chronic subdural hematoma. Measurement of fibrinopeptides].
    Harada K; Orita T; Abiko S; Aoki H
    Neurol Med Chir (Tokyo); 1989 Feb; 29(2):113-6. PubMed ID: 2475799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An analysis of disseminated intravascular coagulation by fibrinopeptides].
    Gando S; Tedo I
    Rinsho Ketsueki; 1988 Dec; 29(12):2250-5. PubMed ID: 3150013
    [No Abstract]   [Full Text] [Related]  

  • 5. Activation of blood coagulation and fibrinolysis in Graves' disease.
    Marongiu F; Conti M; Murtas ML; Mameli G; Sorano GG; Martino E
    Horm Metab Res; 1991 Dec; 23(12):609-11. PubMed ID: 1778596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular markers of hemostatic mechanisms--fibrinopeptide A and fibrinopeptide B beta 15-42].
    Kobayashi N
    Rinsho Byori; 1989 Mar; 37(3):231-3. PubMed ID: 2746916
    [No Abstract]   [Full Text] [Related]  

  • 7. [Wound healing, blood coagulation and fibrinolysis during operations involving gastric cancer surgery].
    Gando S; Kamiya K; Makise H; Tedo I; Nakanishi Y
    Nihon Geka Gakkai Zasshi; 1989 Jan; 90(1):59-63. PubMed ID: 2565016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Action of proteolytic enzymes on fibrinogen].
    Jamet M; Levy G
    Ann Anesthesiol Fr; 1978; 19(8):687-91. PubMed ID: 31111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinopeptide A increases after chorionic villus sampling.
    Al-Gailani F; Elias S; Simpson JL; Green D
    Prenat Diagn; 1987 Oct; 7(8):557-60. PubMed ID: 3684963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormalities of blood coagulation and fibrinolysis in psoriasis.
    Marongiu F; Sorano GG; Bibbò C; Pistis MP; Conti M; Mulas P; Balestrieri A; Biggio P
    Dermatology; 1994; 189(1):32-7. PubMed ID: 7516205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Blood coagulation and fibrinolysis in anesthesia and operations, with special reference to FPA, FPB beta 15-42].
    Gando S; Tedo I; Hanaoka Y; Makise N; Tsujinaga H; Kubota M
    Masui; 1988 Apr; 37(4):451-6. PubMed ID: 3398226
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma concentrations of fibrinopeptide A and fibrinopeptide B beta 15-42 in glomerulonephritis and the nephrotic syndrome.
    Tomura S; Oono Y; Kuriyama R; Takeuchi J
    Arch Intern Med; 1985 Jun; 145(6):1033-5. PubMed ID: 4004427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The polymerization and thrombin-binding properties of des-(B beta 1-42)-fibrin.
    Siebenlist KR; DiOrio JP; Budzynski AZ; Mosesson MW
    J Biol Chem; 1990 Oct; 265(30):18650-5. PubMed ID: 2211727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinopeptide A and fibrinopeptide B beta 15-42 in patients with Behçet's disease.
    Sunakawa M; Okinami S
    Metab Pediatr Syst Ophthalmol (1985); 1988; 11(4):147-8. PubMed ID: 3221795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrin(ogen) peptides in early breast cancer.
    Mannucci PM; Cugno M; Mameli G; Marongiu F; Bianchi Bonomi A
    Thromb Haemost; 1989 Sep; 62(2):819. PubMed ID: 2814934
    [No Abstract]   [Full Text] [Related]  

  • 16. Fibrin metabolism in patients with acute myocardial infarction during and after treatment with tissue-type plasminogen activator.
    Ring ME; Butman SM; Bruck DC; Feinberg WM; Corrigan JJ
    Thromb Haemost; 1988 Dec; 60(3):428-33. PubMed ID: 2976994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemostatic abnormalities and outcome in patients with operable breast cancer.
    McCulloch P; Lowe GD; Douglas JT; Murray GD; George WD
    Eur J Cancer; 1990; 26(9):950-3. PubMed ID: 2149020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Markers of fibrinogen derivatives used in clinical investigation.
    Soria J; Soria C; Mirshahi M; Samama MM
    Semin Thromb Hemost; 1985 Apr; 11(2):129-32. PubMed ID: 2412296
    [No Abstract]   [Full Text] [Related]  

  • 19. Fibrinopeptide A and B beta 15-42 in liver cirrhosis.
    Marongiu F; Mameli G; Acca MR; Mulas G; Medda A; Tronci MB; Mamusa AM; Balestrieri A
    Haemostasis; 1988; 18(2):126-8. PubMed ID: 2457543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased plasmin resistance by clots of a homophenotypic Aalpha R 16H fibrinogen (Kingsport, slower fibrinopeptide A than fibrinopeptide B release).
    Galanakis DK; Neerman-Arbez M; Kudryk B; Henschen A
    Blood Coagul Fibrinolysis; 2010 Mar; 21(2):135-9. PubMed ID: 20019599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.